63
Views
8
CrossRef citations to date
0
Altmetric
Review

Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamide

&
Pages 271-280 | Published online: 26 Mar 2009

References

  • AicardiJLevy GomesAClinical and electroencephalographic symptomatology of the ‘genuine’ Lennox-Gastaut syndrome and its differentiation from other forms of epilepsy of early childhoodEpilepsy Res19926185193
  • FitzgeraldLFStoneJLHughesJRMelynMALanskyLLThe Lennox-Gastaut syndrome: electroencephalographic characteristics, clinical correlates, and follow-up studiesClinical Encephalogr1992234180189
  • MarkandONLennox-Gastaut syndrome (childhood epileptic encepha-lopathy)J Clin Neurophysiol200320642644114734932
  • GentonPGuerrineRDravetCThe Lennox-Gaustaut syndromeMeinardiHHandbook of Clinical Neurology: The Epilepsies, Part IIAmsterdamElsevier Science200073211222
  • GoldsmithILZupancMLBuchhalterJRLong-term seizure outcome in 74 patients with Lennox-Gastaut syndrome: effects of incorporating MRI head imaging in defining the cryptogenic subgroupEpilepsia200041439539910756403
  • GlauserTKlugerGSachdeoRKraussGPerdomoCArroyoSRufinamide for generalized seizures associated with Lennox-Gastaut syndromeNeurology200870211950195818401024
  • GibbsFAGibbsELLennoxWGThe influence of the blood sugar level on the wave and spike formation in petit mal epilepsyArch Neurol Psychiat19394111111116
  • LennoxWGDavisJPClinical correlates of the fast and the slow spike-wave electroencephalogramPediatrics19505462664415417264
  • DravetCEncephalopathic Epileptique de l’Enfant avec Pointe-Onde Lente Diffuse [dissertation] University of Marseille, France1965
  • GastrautHRogerJSoulayrolRChildhood epileptic encepha-lopathy with diffuse slow spike-waves (otherwise known as “petit mal variant”) or Lennox syndromeEpilepsia1966721391794959714
  • OhtaharaSOhtsukaYKobayashiKLennox-Gastaut syndrome: a new vistaPsychiatry and Clin Neurosci1995493S179S183
  • RogerJDravetCBureauMThe Lennox-Gaustaut syndromeCleve-land Clin J Med198956Suppl Pt 2S172S180
  • BauerGBenkeTBohrKThe Lennox-Gaustaut syndrome in adulthoodNiedermeyerEDegenRThe Lennox-Gaustaut SyndromeNew YorkAlan R. Liss Inc1988317328
  • GuerriniRDravetCFerrariARBattagliaAThe evolution of epilepsy in the most common genetic forms with mental retadrdation (Down’s syndrome and fragile X syndrome)Pediatr Med Chir199315Suppl 119228415189
  • BeaumanoirAThe Lennox-Gastaut syndrome: a personal studyElectroencephalogr Clin Neurophysiol1982358599
  • BearmanoirADravetCIeLJLp-The Lennox-Gastaut syndromeRogerJDureauMDravetCDreifussFEPerretAWolfPEpileptic syndromes in infancy, childhood and adolescence19922nd edLondonJohn Libbey1992115132
  • TrevathanEInfantile spasms and Lennox-Gastaut syndromeJ Child Neurol200217Suppl 22S92S2211952036
  • MarkandONSlow spike-wave activity in EEG and associated clinical features: often called ‘Lennox’ or “Lennox-Gastaut” syndromeNeurology1977278746757407485
  • OguniHHayashiKOsawaMLong-term prognosis of Lennox-Gastaut syndromeEpilepsia199637Suppl 344478681912
  • AicardiJGomesALThe Lennox-Gaustaut syndrome Clinical and electroencephalographic featuresNiedermeyerEDegenRThe Lennox-Gaustaut SyndromeNew YorkAlan R. Liss19882546
  • OhtaharaSOhtsukaYYamatogiYEarly infantile epileptic encephalopathy with suppression-burstRogerJBureauMDravetCDreifussPEPeretAWolfPEpileptic syndromes in infancy, childhood, and adolescence2nd edLondonJohn Libbey19922534
  • ChevrieJJAicardiJChildhood epileptic encephalopathy with slow spike-wave. A statistical study of 80 casesEpilepsia19721322592714217690
  • IkenoTShigematsuHMiyakoshiMOhbaAYagiKSeinoMAn analytic study of epileptic fallsEpilepsia19852666126213935426
  • EgliMMothersillIO’KaneMO’KaneFThe axial spasm – the predominant type of drop seizure in patients with secondary generalized epilepsyEpilepsia19852654014154043010
  • BittencourtPRRichensAAnticonvulsant-induced status epilepticus in Lennox-Gastaut syndromeEpilepsia19812211291346781886
  • DiMarioFJJrClancyRRParadoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizuresPediatr Neurol1988442492513149484
  • BeaumanoirAFolettiGMagistrisMVolanschiDStatus epilepticus in the Lennox-Gastaut syndromeNiedermeyerEDegenRThe Lennox-Gaustaut SyndromeNew YorkAlan R. Liss1988283300
  • MotteJTrevathanEArvidssonJFBarreraMNMullensELManascoPLamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study GroupN Engl J Med199733725180718129400037
  • Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). The Felbamate Study Group in Lennox-Gastaut SyndromeN Engl J Med1993328129338347179
  • SachdeoRCGlauserTARitterFReifeRLimPPledgerGA double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study GroupNeurology19995291882188710371538
  • HancockECrossHTreatment of Lennox-Gastaut syndromeCochrane Database Syst Rev20033CD00327712917958
  • FrostMGatesJHelmersSLVagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndromeEpilepsia20014291148115211580762
  • MaeharaTShimizuHSurgical outcome of corpus callosotomy in patients with drop attacksEpilepsia2001421677111207787
  • BialerMJohannessenSIKupferbergHJLevyRHLoiseauPPeruccaEProgress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)Epilepsy Res200143115811137386
  • McLeanMHJSchmutzMPozzaMThe influence of rufinamide on sodium currents and action potential firing in rodent neurons. [abstract]Epilepsia200546Suppl 8296
  • WhiteHSSchmutzMPozzaMWolfHStablesJKupferergHThe anticonvulsant profile and tolerability of rufinamide in mice and rats (abstract)Epilepsia200546Suppl 828015679509
  • PeruccaECloydJCritchleyDFuseauERufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsyEpilepsia20084971123114118503564
  • ArroyoSRufinamideNeurotherapeutics2007415516217199032
  • GlauserTBialerMRufinamidePedleyTEngleJEpilepsy: a comprehensive textbook2nd edPhiladelphiaWolter/Kluwer/Lippincott Williams and Wilkins200716471654
  • WaldmeierFGschwindHPRowanMCMetabolism of the new anticonvulsive trial drug rufinamide (CGP 33101) in healthy male volunteers (abstract)Epilepsia199637Suppl 5167
  • CheungWKKianifardFWongAIntra- and inter-subject variabilities of CGP 33101 after replicate single oral doses of two 200-mg tablets and 400-mg suspensionPharm Res19951212187818828786960
  • SatohTHosokawaMStructure, function and regulation of carboxylesterasesChem Biol Inter20061623195211
  • ChungSWChoiLKaroplehykMAA pharmacokinetic evaluation of rufinamide in elderly and younger subjects [abstract]Epilepsia199839Suppl 659
  • SachdeoRRosenfeldWChoiLYeahC-MCooperAKarolchykMPharmacokinetics and safety of adjunctive runfinamide therapy in pediatric pateints with epilepsy (abstract)Epilepsia199839Suppl 6166167
  • KraussGLPerdomoCAArroyoSShort and long-term safety of rufinamide in patients with epilepsy (abstract)Epilepsia200546Suppl 8205222
  • FuseauECritchleyDPerdomoCArroyoSPopulation pharmacokinetics drug-drug interaction analyses of rufinamide studies in patients with epilepsy. (abstract)Epilepsia200546Suppl 8210211
  • PennellPBOgailyMSMacdonaldRLAplastic anemia in a patient receiving felbamate for complex partial seizuresNeurology1995453 Pt 14564607898696
  • GubermanAHBesagFMBrodieMJLamotrigine-associated rash: risk/benefit considerations in adults and childrenEpilepsia199940798599110403224
  • KeatesEClarkTAcute myopia and secondary angle closure glaucoma: a rare ocular syndrome in topiramate-treated patients (abstract)Neurology20025842211839842
  • Ben-ZeevBWatembergNAugartenAOligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effectJ Child Neurol200318425425712760427
  • MarchandMCritchleyDNagyCFaseusEThe effect of rufinamide concentration on the QT interval in healthy subjects treated during 18 days with multiple ascending doses: a population PK/PD analysis (abstract)Annual Meeting of the Population Approach Group Vol Pamplona, Spain;2005
  • BjerregaardPGussakIShort QT syndromeAnn Noninvasive Electrocardiol200510443644016255754
  • FrenchJAKannerAMBautistaJEfficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyNeurology20046281261127315111660
  • GlauserTKlugerGSachdeoROpen-label extension study of the efficacy and safety of rufinamide adjunctive therapy in patients with Lennox-Gastaut syndrome (abstract)Epilepsia200546Suppl 6408